News & Events

CRAB and Berg Honor Cancer Survivors at Fenway Park

July 10, 2015 - Researchers from Cancer Research And Biostatistics (CRAB), Berg Biosystems and Beth Israel Deaconess Memorial Hospital recognized cancer survivors at a Red Sox vs Yankees game at Fenway Park. CRAB researchers John Crowley, PhD and Amy Stoll-D’Astice, Dr. Ramesh Ramanathan, MD along with Dr. Jim Moser, MD from BIDMC and Niven Narain, CEO of Berg, gathered in Boston for a weekend meeting at Berg’s offices to discuss Project Survival, Berg’s multi-institutional initiative in pancreatic cancer targeted therapies. Amy Stoll-D'Astice called the Fenway Park event "a wonderful recognition of Pancreatic Cancer survivors with a team hoping to “hit it out of the ballpark” with Project Survival". Read more about Project Survival at this link:

2014 Annual Report Published

Click the image above to view or download the report. 


Pancreatic Cancer Biomarker the Goal of “Project Survival”

SEATTLE, June 18, 2015 – Cancer Research And Biostatistics (CRAB) is working through our Pancreatic Cancer Research Team (PCRT) network on "Project Survival," a multi-institutional collaboration targeted at pancreatic cancer to discover breakthrough diagnostics and allow for development of targeted treatments against pancreatic cancer. CRAB and the PCRT network provide the essential infrastructure and expertise for a project with these lofty goals. You can view an interview with Niven Narain, CEO of Berg, with Diedre Bolton of Fox Business on her Risk & Reward show at this link:

More information about the project can be found here:

If you are interested in supporting cancer research please consider a donation to CRAB, a 5013c non-profit research institute. Click here to donate:

CRAB Presented at 2015 Life Science Innovation Northwest

SEATTLE, June 17, 2015 – Tammy Buist, VP and Chief Business Development Officer, represented Cancer Research And Biostatistics (CRAB) and gave a podium presentation at the Life Science Innovation Northwest exposition (LSINW). The event was hosted by the Washington Biotechnology & Biomedical Association (WBBA). Ms. Bust described CRAB's impact on cancer using innovative partnerships and alliances, including the Pacific Rim Cancer Biostatistics Conference that CRAB will host in August and Lung and Pancreatic Cancer clinical trials run through CRAB's clinical trials consortia.

Ms. Bust's presentation was on June 30, 2015, at 2:10 PM in the Innovation section of the conference.